Literature DB >> 7170438

Intracellular origin and regulation of endogenous lipolysis in rat heart.

H Stam, W C Hülsmann.   

Abstract

The rate of glycerol release from isolated, perfused rat hearts was used as an index for endogenous lipolysis. Pharmacological and metabolic interventions were performed in order to obtain information about the intracellular site of action and regulation of tissue triglyceride (TG) hydrolysis in heart. It proved that endogenous lipolysis probably is of lysosomal origin. The activity of tissue lipolysis is dependent on the amount of stored TG and on the contractile status of the heart and is subject to feedback inhibition by production of fatty acids. Evidence is presented that Ca2+ plays an important role in the regulation and hormonal modification of lipolysis since all mechanisms inducing alterations in Ca2+ homeostasis influence myocardial lipolysis. Our experimental data and current knowledge are discussed in the light of a new hypothesis which relates intracellular Ca2+ and the rate of fatty acid utilization to the activity (activities) of tissue lipase(s). It is proposed that inhibition of endogenous lipolysis may be the main mechanism of action of antiarrhythmic agents (lidocaine, quinidine, phenothiazines).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7170438     DOI: 10.1007/978-1-4899-5561-6_47

Source DB:  PubMed          Journal:  Adv Myocardiol        ISSN: 0270-4056


  4 in total

1.  Relation between lipolysis and glycolysis during ischemia in the isolated rat heart.

Authors:  V Trach; E Buschmans-Denkel; W Schaper
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

2.  Intracoronary infusion of small doses of nifedipine lowers regional myocardial O2-consumption without altering regional myocardial function.

Authors:  P D Verdouw; F J ten Cate; J M Hartog; M G Scheffer; H Stam
Journal:  Basic Res Cardiol       Date:  1982 Jan-Feb       Impact factor: 17.165

Review 3.  Hormones and triacylglycerol metabolism under normoxic and ischemic conditions.

Authors:  K Schoonderwoerd; T van der Kraaij; W C Hülsmann; H Stam
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

4.  Cardiovascular actions of the calmodulin inhibitor felodipine.

Authors:  P D Verdouw; B H Wolffenbuttel; M G Scheffer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-08       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.